The effect and mechanism of miR-210 in down-regulating the autophagy of lung cancer cells.


Journal

Pathology, research and practice
ISSN: 1618-0631
Titre abrégé: Pathol Res Pract
Pays: Germany
ID NLM: 7806109

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 21 09 2018
revised: 27 11 2018
accepted: 11 12 2018
pubmed: 24 12 2018
medline: 11 4 2019
entrez: 22 12 2018
Statut: ppublish

Résumé

This project aims to investigate the roles of miR-210 in autophagy of lung cancer cells and the related mechanism. The expressions of miR-210 and ATG7 in 30 cancer tissues and the adjacent tissues in patients with lung cancer were compared using RT-qPCR methods, Western Blot assay was carried out to test the expression of ATG7 in protein. Moreover, the dual luciferase reporter gene assay system was used to confirm ATG7 is a target gene of miR-210. Furthermore, lung cancer cell line A549 was transfected with either miR-210 mimics or inhibitors and RT-qPCR methods was used to detect the expression of miR-210 and ATG7. Next, MTT assay was used to examine the effect of miR-210 on the growth of the lung cancer cells, and finally, the expression of autophagy related genes, ATG7, LC3-II/LC3-I and Beclin-1 were detected by Western Blot and ICC assay. We observed that miR-210 was significantly increased and ATG7 was markedly decreased in cancer tissue of patients with lung cancer compared with normal tissue. Moreover, results of dual luciferase reporter assay indicated that ATG7 is a direct target of miR-210. Next, transfection of miR-210 mimics in lung cancer cells induced significant increase in cell proliferation, and transfection of miR-210 inhibitors lead to inhibited cell proliferation. Furthermore, over-expression of miR-210 induced marked decrease in the expression of ATG7, LC3-II/LC3-I and Beclin-1, while transfection of miR-210 inhibitors induced significant increase in the expression of ATG7, LC3-II/LC3-I and beclin-1. Our results suggested that miR-210 plays a great role in autophagy of lung cancer cell by targeting ATG7.

Identifiants

pubmed: 30573163
pii: S0344-0338(18)31270-6
doi: 10.1016/j.prp.2018.12.018
pii:
doi:

Substances chimiques

MIRN210 microRNA, human 0
MicroRNAs 0
ATG7 protein, human EC 6.2.1.45
Autophagy-Related Protein 7 EC 6.2.1.45

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

453-458

Informations de copyright

Copyright © 2018. Published by Elsevier GmbH.

Auteurs

Sheng Ju (S)

Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China.

Zhipan Liang (Z)

Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China.

Chang Li (C)

Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China.

Cheng Ding (C)

Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China.

Chun Xu (C)

Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China.

Xinyu Song (X)

Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China.

Jun Zhao (J)

Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China. Electronic address: drjunzhao@yandex.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH